THURSDAY, SEPTEMBER 21, 2017

Research into hantavirus treatments shows purified antibodies can protect against disease

SAB Biotherapeutics, Inc., (SAB) and the U.S. Read More »

Ebola monitoring ends for Texas hospital employee

The last person in Texas under surveillance in connection to the state's three confirmed Ebola cases completed the 21-day quarantine period on Friday and has been released from monitoring. Read More »

Anti-malaria compound developed; human trials to begin

A team of international scientists led by researchers from St. Jude Children’s Hospital has discovered a compound that destroys malaria-infected red blood cells without harming healthy cells. Read More »

MRIGlobal awarded $3 million to create new HPV vaccine

The National Cancer Institute's PREVENT Cancer Program recently awarded MRIGlobal a $3 million contract to create and develop a vaccine for a human papillomavirus (HPV), which will be used in a future Phase I clinical trial. Read More »

PaxVax will seek FDA approval of single-dose cholera vaccine

PaxVax, Inc. announced positive results today from a Phase 3 trial of its oral cholera vaccine candidate PXVX0200. Read More »

Malaria mortality rates plummet

A report from the World Health Organization (WHO) released today shows that malaria deaths worldwide fell by 47 percent between 2000 and 2013. Read More »

Severe flu strains appear to be season's biggest threat

The Centers for Disease Control and Prevention (CDC) encourages all citizens to receive their influenza vaccines in light of the data predicting a severe flu season for 2014. Read More »

Study: Injectable vaccines soon may fight cancer, deadly pathogens

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences (SEAS) recently discovered that a nonsurgical injection of biomaterial can potentially prevent and fight cancer and deadly infections such as HIV and Ebola. Read More »

Study finds HPV vaccine has no effect on teen female sexual activity

Queen’s University researchers said their research indicates that the sexual behavior of teen girls is not impacted by the human papilloma virus vaccine. Read More »

Malaria mortality rates decrease

The World Health Organization (WHO) recently released a report that showed a dramatic decrease in the number of deaths caused by malaria. Read More »

Flu vaccines increase immunity against multiple viruses

Researchers at St. Jude Children's Research Hospital recently found that seasonal flu vaccines may boost immune systems against multiple flu viruses and not just the viruses in the vaccine. Read More »

Valneva's first Phase II trials on TB vaccine show promise

European biotechnology company Valneva SE said recently that its Statens Serum Institut’s (SSI) tuberculosis (TB) vaccine candidate H1/IC31, formulated with Valneva’s proprietary adjuvant IC31, showed positive results in Phase II trials. Read More »

HHS chief's legal-immunity order aims to further Ebola vaccine efforts

Health and Human Services Secretary Sylvia Burwell has taken the initiative to facilitate the development and availability of experimental Ebola vaccines. Read More »

Researchers propose new dengue virus treatments

A team of researchers from the Julius Maximilian University of Wurzburg and the Johannes Gutenberg University Mainz in Germany recently proposed new treatment methods for dengue virus. Read More »

Doctors Without Borders go door-to-door to share antimalarial drugs in Sierra Leone

Doctors Without Borders (MSF) and Sierra Leone's Ministry of Health recently administered the largest distribution of antimalarial drugs in Freetown and five neighboring districts. Read More »

Integral Molecular IDs human antibodies that fight Chikungunya virus

Integral Molecular may have found a way for the body to fight the mosquito-borne Chikungunya virus (CHIKV). Read More »

Gavi aims to spend $300 million on Ebola vaccines for ravaged countries

Gavi, the Vaccine Alliance, said recently it plans to purchase and distribute millions of doses of an Ebola vaccine to support large-scale efforts in affected countries as soon as an effective vaccine is approved by the World Health Organization. Read More »

Study finds flu virus, vaccine effect closely tied

A Swiss study released Thursday said how much protection the flu shot provides depends on how closely the vaccine matches the circulating virus. Read More »

New research suggests MERS epidemic unlikely

Researchers recently performed new studies on Middle East respiratory syndrome coronavirus (MERS-CoV) and determined that it is unlikely MERS will become an epidemic. Read More »

U.N.: Ebola nations need a more preventive strategy

As the worldwide Ebola outbreak worsens, United Nations Economic and Social Council (ECOSOC) President Martin Sajdik said Thursday that he wants measures in place to ensure that responses circle back to long-term efforts to strengthen health systems in affected countries. Read More »